AAAPT Diagnostic Criteria for Acute Knee Arthroplasty Pain

Pain Med. 2020 May 1;21(5):1049-1060. doi: 10.1093/pm/pnz355.

Abstract

Objective: The relationship between preexisting osteoarthritic pain and subsequent post-total knee arthroplasty (TKA) pain is not well defined. This knowledge gap makes diagnosis of post-TKA pain and development of management plans difficult and may impair future investigations on personalized care. Therefore, a set of diagnostic criteria for identification of acute post-TKA pain would inform standardized management and facilitate future research.

Methods: The Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership with the US Food and Drug Administration (FDA), the American Pain Society (APS), and the American Academy of Pain Medicine (AAPM) formed the ACTTION-APS-AAPM Pain Taxonomy (AAAPT) initiative to address this goal. A multidisciplinary work group of pain experts was invited to conceive diagnostic criteria and dimensions of acute post-TKA pain.

Results: The working group used contemporary literature combined with expert opinion to generate a five-dimensional taxonomical structure based upon the AAAPT framework (i.e., core diagnostic criteria, common features, modulating factors, impact/functional consequences, and putative mechanisms) that characterizes acute post-TKA pain.

Conclusions: The diagnostic criteria created are proposed to define the nature of acute pain observed in patients following TKA.

Keywords: AAAPT; ACTTION; Acute pain; knee arthroplasty; taxonomy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Pain* / diagnosis
  • Arthroplasty, Replacement, Knee* / adverse effects
  • Humans
  • Pain Measurement
  • Public-Private Sector Partnerships
  • United States
  • United States Food and Drug Administration